Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Sell

C

Exact Sciences Corp (EXAS)

Services-medical Laboratories

https://www.exactsciences.com

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.

5505 ENDEAVOR LANE
MADISON, WI

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/30/2001

Market Cap

10,947,622,500

Shares Outstanding

180,850,000

Weighted SO

180,849,944

Total Employees

N/A

Upcoming Earnings

07/31/2024

Similar Tickers

NTRA --.--%

CDNA --.--%

ILMN --.--%

TWST --.--%

A --.--%

TMO --.--%

NVTA --.--%

DHR --.--%

Beta

1.2250

Last Div

0.0000

Range

40.62-85.71

Chg

0.7800

Avg Vol

3082506

Mkt Cap

10947622500

Exch

NASDAQ

Country

US

Phone

608 284 5700

DCF Diff

23.3089

DCF

44.1711

Div Yield

0.0000

P/S

4.1913

EV Multiple

-5577.2600

P/FV

3.4208

Div Yield %

0.0000

P/E

-62.4003

PEG

-1.9721

Payout

0.0000

Current Ratio

2.1723

Quick Ratio

1.9818

Cash Ratio

0.7929

DSO

37.4592

DIO

64.2496

Op Cycle

101.7088

DPO

26.7242

CCC

74.9845

Gross Margin

0.7230

Op Margin

-0.0726

Pretax Margin

-0.0659

Net Margin

-0.0670

Eff Tax Rate

-0.0169

ROA

-0.0262

ROE

-0.0556

ROCE

-0.0316

NI/EBT

1.0169

EBT/EBIT

0.9078

EBIT/Rev

-0.0726

Debt Ratio

0.3898

D/E

0.8148

LT Debt/Cap

0.4207

Total Debt/Cap

0.4490

Int Coverage

-8.4408

CF/Debt

0.0456

Equity Multi

2.0904

Rec Turnover

9.7439

Pay Turnover

13.6580

Inv Turnover

5.6810

FA Turnover

3.0221

Asset Turnover

0.3914

OCF/Share

0.6438

FCF/Share

-0.0812

Cash/Share

5.1368

OCF/Sales

0.0454

FCF/OCF

-0.1261

CF Coverage

0.0456

ST Coverage

0.4188

CapEx Coverage

0.8880

Div&CapEx Cov

0.8880

P/BV

3.4208

P/B

3.4208

P/S

4.1913

P/E

-62.4003

P/FCF

-731.7929

P/OCF

92.0291

P/CF

92.0291

PEG

-1.9721

P/S

4.1913

EV Multiple

-5577.2600

P/FV

3.4208

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 26, 01:30 Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™. GlobeNewswire Inc. Nov 27, 00:30 Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology GlobeNewswire Inc. Sep 13, 00:30 Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights Investing.com Jan 17, 12:50 Time to Buy These 3 Healthcare Companies That Raised Revenue Guidance? Benzinga Jan 02, 21:54 Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock Benzinga Jan 02, 21:54 Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock Benzinga Jan 02, 15:00 A Glimpse Into The Expert Outlook On Exact Sciences Through 5 Analysts Benzinga Dec 20, 13:47 Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? The Motley Fool Dec 17, 05:43 1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest The Motley Fool Dec 17, 05:43 1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest The Motley Fool Dec 13, 08:45 Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences? The Motley Fool Nov 26, 07:56 A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest The Motley Fool Nov 26, 07:56 A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest The Motley Fool Nov 26, 07:56 A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest The Motley Fool Nov 20, 07:30 2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030 The Motley Fool Nov 02, 00:30 Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript The Motley Fool Nov 02, 00:30 Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript The Motley Fool Nov 02, 00:30 Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript Benzinga Nov 01, 07:32 Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News' Benzinga Oct 30, 03:40 Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week

Revenue Product Segmentation